Multiple marker screening in multifetal gestations: Failure to predict adverse pregnancy outcomes

Fetal Diagnosis and Therapy

Volumn 11, Issue 1, 1996, Pages 16-19

  Krivchenia, Eric L ^d   Johnson, Mark P ^d   Sokol, Robert J ^d   Evans, Mark I ^d  

^a RAMBAM MEDICAL CENTER   (Israel)

^b Teterboro   (Israel)

^c MetPath Laboratories   (United States)

^d HUTZEL HOSPITAL   (United States)

Author keywords

Alpha fetoprotein; Human chorionic gonadotropin; Multiple gestation

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ADULT; AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; CORRELATION FUNCTION; FEMALE; FETUS KARYOTYPING; FETUS MALFORMATION; HUMAN; HUMAN EXPERIMENT; MATERNAL SERUM; MULTIPLE PREGNANCY; NORMAL HUMAN; PREDICTION; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; STILLBIRTH;

EID: 0030067510     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000264273     Document Type: Article

References (12)

1. Nelson LH, Bensen J, Burton BK: Outcomes in patients with unusually high alpha-fetoprotein levels. Am J Obstet Gynecol 1987,157: 572-576.
2. Williams MA, Hickok DE, Zing-hcim RW, Luthy DA, Kimclman J, Nyberg DA, Mahony BS: Elevated maternal serum alpha-fetoprotein levels and mid trimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol 1992,167: 1032-1037.
3. Larson JM, Pretorius DH, Budorick NE, Scioscia AL: Value of maternal serum alpha-fetoprotein levels of 5.0 MoM or greater and prenatal sonography in predicting fetal outcome. Radiology 1993;189:77-81.
4. Beekhuis JR, Van Lith JM, De Wolf BT, Mantingh A: Increased maternal serum alpha-fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndrome. Prenat Diagn 1992;12:643-647.
5. Tanaka M, Natori M, Kohno H, Ishimoto H, Kobayashi T, Nozawa S: Fetal growth in patients with elevated maternal serum HCG levels. Obstet Gynecol 1993;81:341-343.
6. Gravett CP, Buckmaster JG, Watson PT, Gravett MG: Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcomes. Am J Med Genet 1992;44:485-486.
7. Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M: The association between unexplained second trimester maternal serum HCG elevation and pregnancy complications. Obstet Gynecol 1992:80:83-86.
8. Drugan A, O’Brien JE, Gambino R, Johnson MP, Evans MI: Similarity of twins to singleton maternal serum alpha-fetoprotein ratio by race: No need to establish specific multifetal tables. Fetal Diagn Ther 1993:8:84-88.
9. Evans MI, Chik L, O'Brien JE, Chen B, Dvorin E, Ayoub M, Krivchenia EL, Ager JW, Johnson MP, Sokol RJ: MOMs and DADs: Improved specificity and cost effectiveness of biochemical screening for aneuploi-dy with DADs. Am J Obstet Gynecol 1995;172:1138-1147.
10. Wald N, Cuckle H, Wu TS, George L: Maternal serum unconjugatcd es-triol and human chorionic gonadotropin levels in twin pregnancies: Implications for screening for Down's syndrome. Br J Obstet Gynaecol 1991;98:905-908.
11. Spencer K, Salonen R, Muller F: Down’s syndrome screening in multiple pregnancies using alpha-feto-protcin and free beta HCG. Prenat Diagn 1994;14:537-542.
12. Evans MI, Chik L, O’Brien JE, Dvorin E, Johnson MP, Krivchenia E, Sokol RJ: Logis regression generated probability estimates for trisomy 21 outcomes from serum AFP and bHCG. Simplification with increased specificity. J Matem Fetal Med, in press.